COVID-19 in people with rheumatic diseases: risks, outcomes, treatment considerations
The COVID-19 pandemic has brought challenges for people with rheumatic disease in
addition to those faced by the general population, including concerns about higher risks of …
addition to those faced by the general population, including concerns about higher risks of …
Risk and prognosis of SARS-CoV-2 infection and vaccination against SARS-CoV-2 in rheumatic and musculoskeletal diseases: a systematic literature review to inform …
FPB Kroon, A Najm, A Alunno, JW Schoones… - Annals of the …, 2022 - ard.bmj.com
Objectives Perform a systematic literature review (SLR) on risk and prognosis of SARS-CoV-
2 infection and vaccination against SARS-CoV-2 in patients with rheumatic and …
2 infection and vaccination against SARS-CoV-2 in patients with rheumatic and …
Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician …
Objectives To describe the safety of vaccines against SARS-CoV-2 in people with
inflammatory/autoimmune rheumatic and musculoskeletal disease (I-RMD). Methods …
inflammatory/autoimmune rheumatic and musculoskeletal disease (I-RMD). Methods …
A randomized, placebo‐controlled phase III extension trial of the long‐term safety and tolerability of anifrolumab in active systemic lupus erythematosus
Objective To explore long‐term safety and tolerability of anifrolumab 300 mg compared with
placebo in patients with systemic lupus erythematosus (SLE) who completed a Treatment of …
placebo in patients with systemic lupus erythematosus (SLE) who completed a Treatment of …
The flare of rheumatic disease after SARS-CoV-2 vaccination: a review
Y **e, Y Liu, Y Liu - Frontiers in Immunology, 2022 - frontiersin.org
As the coronavirus disease 2019 (COVID-19) pandemic continues worldwide, vaccination
has been considered an effective measure to protect people from the COVID-19 and end the …
has been considered an effective measure to protect people from the COVID-19 and end the …
Baseline factors associated with self-reported disease flares following COVID-19 vaccination among adults with systemic rheumatic disease: results from the COVID …
Objective To examine the frequency of, and risk factors for, disease flare following COVID-19
vaccination in patients with systemic rheumatic disease (SRD). Methods An international …
vaccination in patients with systemic rheumatic disease (SRD). Methods An international …
American College of Rheumatology guidance for COVID‐19 vaccination in patients with rheumatic and musculoskeletal diseases: version 4
JR Curtis, SR Johnson, DD Anthony… - Arthritis & …, 2022 - Wiley Online Library
Objective To provide guidance to rheumatology providers on the use of COVID‐19 vaccines
for patients with rheumatic and musculoskeletal diseases (RMDs). Methods A task force was …
for patients with rheumatic and musculoskeletal diseases (RMDs). Methods A task force was …
One year in review 2022: systemic lupus erythematosus
D Zucchi, E Elefante, D Schilirò, V Signorini… - Clinical and …, 2022 - sfera.unife.it
Systemic lupus erythematosus (SLE) is a chronic multisystem auto-immune disease with
extremely varied clinical manifestations and a complex pathogenesis. New insights in SLE …
extremely varied clinical manifestations and a complex pathogenesis. New insights in SLE …
The use of COVID-19 vaccines in patients with SLE
W Tang, Y Gartshteyn, E Ricker, S Inzerillo… - Current rheumatology …, 2021 - Springer
Abstract Purpose of Review Three COVID-19 vaccines obtained emergency authorization
from the Food and Drug Administration (FDA) and are widely used in the USA …
from the Food and Drug Administration (FDA) and are widely used in the USA …
Side effects and flares risk after SARS-CoV-2 vaccination in patients with systemic lupus erythematosus
E Zavala-Flores, J Salcedo-Matienzo… - Clinical …, 2022 - Springer
The objective of this study is to identify post SARS-CoV-2 vaccine BNT162b2 (BioNTech &
Pfizer) side effects in patients with systemic lupus erythematosus (SLE) at the Cayetano …
Pfizer) side effects in patients with systemic lupus erythematosus (SLE) at the Cayetano …